𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Long-term Therapy With Tenofovir Is Effective for Patients Co-Infected With Human Immunodeficiency Virus and Hepatitis B Virus

✍ Scribed by Theodora E.M.S. de Vries–Sluijs; Jurriën G.P. Reijnders; Bettina E. Hansen; Hans L. Zaaijer; Jan M. Prins; Suzan D. Pas; Martin Schutten; Andy I.M. Hoepelman; Clemens Richter; Jan W. Mulder; Rob A. de Man; Harry L.A. Janssen; Marchina E. van der Ende


Book ID
119761704
Publisher
Elsevier Science
Year
2010
Tongue
English
Weight
885 KB
Volume
139
Category
Article
ISSN
0016-5085

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Hepatitis B virus genotype G: Prevalence
✍ Doan Y. Dao; Jody Balko; Nahid Attar; Enayet Neak; He-Jun Yuan; William M. Lee; 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 155 KB 👁 2 views

## Abstract Relatively little is known about the role of hepatitis B virus (HBV) genotype G (HBV/G) in patients co‐infected with human immunodeficiency virus (HIV) and HBV. This study examined the prevalence and association of HBV/G to liver fibrosis in co‐infected patients. HBV genotypes were dete

Long-term incidence of hepatitis B virus
✍ Yves Benhamou; Marie Bochet; Vincent Thibault; Vincent Di Martino; Eric Caumes; 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 82 KB 👁 2 views

Hepatitis B virus (HBV) resistance to lamivudine has not been extensively documented in human immunodeficiency virus (HIV)-infected patients. We studied the long-term incidence of HBV resistance to lamivudine in HIV-positive patients. Sixty-six HIV-HBV-coinfected patients were studied while receivin

Long-term beneficial effect of interfero
✍ Shi-Ming Lin; I-Shyan Sheen; Rong-Nan Chien; Chia-Ming Chu; Yun-Fan Liaw 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 60 KB 👁 2 views

To examine the long-term effect of interferon (IFN) therapy in patients with chronic hepatitis B virus (HBV) infection, particularly on survival and hepatocellular carcinoma (HCC) prevention, 101 male patients with chronic hepatitis B in a randomized controlled trial were followed up for 1.1 to 11.5